← Back to Search

MRI Scan for Crohn's Disease with Sacroiliitis

N/A
Waitlist Available
Led By Fardina Malik, MD
Research Sponsored by NYU Langone Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up intervention visit 1 (day 1)
Awards & highlights

Study Summary

This trial will further investigate imaging findings of possible sacroiliitis in Crohn's Disease patients by recalling subjects who had findings of possible sacroiliitis on prior MRE and assess the natural history and outcome of these cases.

Who is the study for?
This trial is for adults over 18 with Crohn's Disease who've had signs of sacroiliitis on earlier MRI scans between 2014 and 2018. They must know their HLA-B27 status and have recent ESR and CRP test results. It's not for critically ill or pregnant patients, those who can't follow the study plan, have had cancer (except certain skin cancers) in the last five years, speak only non-English, or can't have an MRI.Check my eligibility
What is being tested?
The study is looking at how sacroiliitis develops in people with Crohn's Disease by recalling patients who showed possible sacroiliitis on previous MRIs. Participants will undergo standard MRI and x-ray imaging of their sacroiliac joints to track changes over time.See study design
What are the potential side effects?
Since this trial involves standard MRI scans and x-rays, side effects are minimal but may include discomfort from lying still during the scan or a very low risk of reaction to contrast materials if used.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~intervention visit 1 (day 1)
This trial's timeline: 3 weeks for screening, Varies for treatment, and intervention visit 1 (day 1) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Significance of sacroiliitis features/lesions seen on Magnetic Resonance Enterography (MRE)
Secondary outcome measures
Measurement of Ankylosing Spondylitis Disease Activity
Measurement of Bath Ankylosing Spondylitis Disease Activity Index
Ankylosing spondylitis
+2 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Crohn's disease (CD) subjectsExperimental Treatment1 Intervention
These subjects will then undergo T1 and STIR sequence MRI of SI joints (pelvis MRI) as well as SIJ plain X-ray for assessment of radiographic sacroiliitis.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
MRI scan
2022
Completed Phase 4
~2690

Find a Location

Who is running the clinical trial?

Spondyloarthritis Research and Treatment NetworkNETWORK
1 Previous Clinical Trials
501 Total Patients Enrolled
NYU Langone HealthLead Sponsor
1,368 Previous Clinical Trials
839,699 Total Patients Enrolled
Fardina Malik, MDPrincipal InvestigatorNYU Langone Health

Media Library

MRI scan Clinical Trial Eligibility Overview. Trial Name: NCT05203926 — N/A
Sacroiliitis Research Study Groups: Crohn's disease (CD) subjects
Sacroiliitis Clinical Trial 2023: MRI scan Highlights & Side Effects. Trial Name: NCT05203926 — N/A
MRI scan 2023 Treatment Timeline for Medical Study. Trial Name: NCT05203926 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Significance and Outcome of Magnetic Resonance Enterography Revealing Sacroiliitis in Crohn's Disease: A Pilot Study
2022. "Significance and Outcome of Magnetic Resonance Enterography Revealing Sacroiliitis in Crohn's Disease: A Pilot Study". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05203926.
All > Crohns Disease
~9 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top